OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII )
Meir Bialer, Svein I. Johannessen, René H. Levy, et al.
Epilepsia (2017) Vol. 58, Iss. 2, pp. 181-221
Open Access | Times Cited: 100
Meir Bialer, Svein I. Johannessen, René H. Levy, et al.
Epilepsia (2017) Vol. 58, Iss. 2, pp. 181-221
Open Access | Times Cited: 100
Showing 1-25 of 100 citing articles:
Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group
Eric H. Kossoff, Beth Zupec‐Kania, Stéphane Auvin, et al.
Epilepsia Open (2018) Vol. 3, Iss. 2, pp. 175-192
Open Access | Times Cited: 586
Eric H. Kossoff, Beth Zupec‐Kania, Stéphane Auvin, et al.
Epilepsia Open (2018) Vol. 3, Iss. 2, pp. 175-192
Open Access | Times Cited: 586
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 208
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 208
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2340-2364
Open Access | Times Cited: 137
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2340-2364
Open Access | Times Cited: 137
Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy
Lara Jehi, Nathalie Jetté, Churl‐Su Kwon, et al.
Epilepsia (2022) Vol. 63, Iss. 10, pp. 2491-2506
Open Access | Times Cited: 91
Lara Jehi, Nathalie Jetté, Churl‐Su Kwon, et al.
Epilepsia (2022) Vol. 63, Iss. 10, pp. 2491-2506
Open Access | Times Cited: 91
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
Yi Wang, Chen Zhong
Pharmacology & Therapeutics (2019) Vol. 201, pp. 77-93
Closed Access | Times Cited: 126
Yi Wang, Chen Zhong
Pharmacology & Therapeutics (2019) Vol. 201, pp. 77-93
Closed Access | Times Cited: 126
A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
Yunfeng Li
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107494-107494
Closed Access | Times Cited: 123
Yunfeng Li
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107494-107494
Closed Access | Times Cited: 123
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2018) Vol. 59, Iss. 10, pp. 1811-1841
Open Access | Times Cited: 117
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2018) Vol. 59, Iss. 10, pp. 1811-1841
Open Access | Times Cited: 117
Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
Brian D. Klein, Catherine Jacobson, Cameron S. Metcalf, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1939-1948
Closed Access | Times Cited: 113
Brian D. Klein, Catherine Jacobson, Cameron S. Metcalf, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1939-1948
Closed Access | Times Cited: 113
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)AReceptor
Gabriel Martinez Botella, Francesco G. Salituro, Boyd L. Harrison, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 18, pp. 7810-7819
Closed Access | Times Cited: 107
Gabriel Martinez Botella, Francesco G. Salituro, Boyd L. Harrison, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 18, pp. 7810-7819
Closed Access | Times Cited: 107
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
The role of adenosine in epilepsy
Landen Weltha, Jesica Reemmer, Detlev Boison
Brain Research Bulletin (2018) Vol. 151, pp. 46-54
Open Access | Times Cited: 99
Landen Weltha, Jesica Reemmer, Detlev Boison
Brain Research Bulletin (2018) Vol. 151, pp. 46-54
Open Access | Times Cited: 99
Brexanolone as adjunctive therapy in super‐refractory status epilepticus
Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright, et al.
Annals of Neurology (2017) Vol. 82, Iss. 3, pp. 342-352
Open Access | Times Cited: 89
Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright, et al.
Annals of Neurology (2017) Vol. 82, Iss. 3, pp. 342-352
Open Access | Times Cited: 89
Brief history of anti‐seizure drug development
Jong M. Rho, H. Steve White
Epilepsia Open (2018) Vol. 3, Iss. S2, pp. 114-119
Open Access | Times Cited: 87
Jong M. Rho, H. Steve White
Epilepsia Open (2018) Vol. 3, Iss. S2, pp. 114-119
Open Access | Times Cited: 87
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy
Debopam Samanta
Pediatric Neurology (2019) Vol. 96, pp. 24-29
Closed Access | Times Cited: 77
Debopam Samanta
Pediatric Neurology (2019) Vol. 96, pp. 24-29
Closed Access | Times Cited: 77
Neuroinflammation: A Signature or a Cause of Epilepsy?
Enrico Pracucci, Vinoshene Pillai, Didi Lamers, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6981-6981
Open Access | Times Cited: 69
Enrico Pracucci, Vinoshene Pillai, Didi Lamers, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6981-6981
Open Access | Times Cited: 69
Modelling epilepsy in the mouse: challenges and solutions
Grant F. Marshall, Alfredo Gonzalez-Sulser, Catherine M. Abbott
Disease Models & Mechanisms (2021) Vol. 14, Iss. 3
Open Access | Times Cited: 57
Grant F. Marshall, Alfredo Gonzalez-Sulser, Catherine M. Abbott
Disease Models & Mechanisms (2021) Vol. 14, Iss. 3
Open Access | Times Cited: 57
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 29
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 29
<p>Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects</p>
Alessandra Morano, Martina Fanella, Mariarita Albini, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 381-396
Open Access | Times Cited: 66
Alessandra Morano, Martina Fanella, Mariarita Albini, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 381-396
Open Access | Times Cited: 66
Chirality as an Important Factor for the Development of New Antiepileptic Drugs
Michał Abram, Marcin Jakubiec, Krzysztof Kamiński
ChemMedChem (2019) Vol. 14, Iss. 20, pp. 1744-1761
Closed Access | Times Cited: 62
Michał Abram, Marcin Jakubiec, Krzysztof Kamiński
ChemMedChem (2019) Vol. 14, Iss. 20, pp. 1744-1761
Closed Access | Times Cited: 62
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 16
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 16
A resurging boom in new drugs for epilepsy and brain disorders
Iyan Younus, Doodipala Samba Reddy
Expert Review of Clinical Pharmacology (2017) Vol. 11, Iss. 1, pp. 27-45
Closed Access | Times Cited: 60
Iyan Younus, Doodipala Samba Reddy
Expert Review of Clinical Pharmacology (2017) Vol. 11, Iss. 1, pp. 27-45
Closed Access | Times Cited: 60
Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy
Melissa Barker‐Haliski, Kristina Johnson, P. R. Billingsley, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1904-1918
Open Access | Times Cited: 59
Melissa Barker‐Haliski, Kristina Johnson, P. R. Billingsley, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1904-1918
Open Access | Times Cited: 59
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2018) Vol. 59, Iss. 10, pp. 1842-1866
Open Access | Times Cited: 49
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2018) Vol. 59, Iss. 10, pp. 1842-1866
Open Access | Times Cited: 49
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2365-2385
Open Access | Times Cited: 47
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2365-2385
Open Access | Times Cited: 47
